CN Patent

CN112390812A — 瑞卢戈利化合物的晶型和无定型固体及其制备方法

Assigned to Zhejiang Yizhong Chemical Co ltd · Expires 2021-02-23 · 5y expired

What this patent protects

本发明申请一种促性腺激素释放素（GnRH）受体拮抗剂药物瑞卢戈利的晶型，无定型及其制备方法，涉及化学医药领域。本发明所提供的晶型，无定型有较好的稳定性，对药物活性成分的纯化过程，药物的制剂过程有较大的意义。

USPTO Abstract

本发明申请一种促性腺激素释放素（GnRH）受体拮抗剂药物瑞卢戈利的晶型，无定型及其制备方法，涉及化学医药领域。本发明所提供的晶型，无定型有较好的稳定性，对药物活性成分的纯化过程，药物的制剂过程有较大的意义。

Drugs covered by this patent

Patent Metadata

Patent number
CN112390812A
Jurisdiction
CN
Classification
—
Expires
2021-02-23
Drug substance claim
No
Drug product claim
No
Assignee
Zhejiang Yizhong Chemical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.